arm vein thrombosis upper extremity deep vein thrombosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients from the emergency department, in and out patient clinic with clinically suspected UEDVT will be eligible for the study.
Exclusion criteria
Exclusion criteria: - No informed consent obtained - Legal age limitation (country specific) - Use of anticoagulants in therapeutic dosages longer than 24 hours prior to randomisation - Prior vein thrombosis in the same arm - Life expectancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint will be the cumulative 3-month incidence of objectively confirmed symptomatic venous thromboembolic events including UEDVT and PE in patients with a normal diagnostic work-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Netherlands